Brief: Cytrx reports strategic realignment of clinical development team

LadRx

06/11/2017 14:00

Nov 6 (Reuters) - Cytrx Corp  CYTR.O : 
    * Cytrx announces strategic realignment of clinical 
development 
team 
    * Cytrx - announced strategic realignment of drug 
development 
efforts for advancing new drug candidates based on ladr 
technology platform 
    * Cytrx Corp - co's drug development, manufacturing and 
regulatory 
activities will be led by Hurley Consulting Associates 
    * Cytrx Corp - is poised to file INDS with FDA for one or 
more 
new ladr drug conjugates in 2018 
 
Source text for Eikon:  ID:nPn3KfMn8a  
Further company coverage:  CYTR.O  
 
 ((bangalore.newsroom@thomsonreuters.com;))